Order Article Reprints

Brenner AK, Aasebø E, Hernandez-Valladares M, Selheim F, Berven F, Grønningsæter I-S, Bartaula-Brevik S, Bruserud Ø. The Capacity of Long-Term In Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome. Cancers. 2019; 11(1):73. https://doi.org/10.3390/cancers11010073

Brenner, Annette K., Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik, and Øystein Bruserud. 2019. "The Capacity of Long-Term In Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome" Cancers 11, no. 1: 73. https://doi.org/10.3390/cancers11010073

Brenner, A. K., Aasebø, E., Hernandez-Valladares, M., Selheim, F., Berven, F., Grønningsæter, I.-S., Bartaula-Brevik, S., & Bruserud, Ø. (2019). The Capacity of Long-Term In Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome. Cancers, 11(1), 73. https://doi.org/10.3390/cancers11010073